Global Liver Institute
News
GLOBAL LIVER INSTITUTE
GLI Commends Repurposed Livmarli’s FDA Approval for Patients over 5 with PFIC
(Washington, D.C. March 14, 2024) –Global Liver Institute (GLI) celebrates a win for rare disease patients with the breaking news of the U.S. FDA’s approval for Mirum Pharmaceuticals’ Livmarli to treat cholestasis pruritus in patients 5 and older that have been diagnosed with progressive familial intrahepatic cholestasis (PFIC), a rare, genetic disorder in which bile builds up in the liver.
FDA’s Approval of Breakthrough NASH Treatment Opens Door for a Long-Neglected Patient Population
Today, Global Liver Institute (GLI) recognizes the importance of the first approval by the U.S. Food and Drug Administration (FDA) of a medication for nonalcoholic steatosis (NASH). Developed by Madrigal Pharmaceuticals, Rezdiffra™ (resmetirom) was approved for the treatment of adults with noncirrhotic NASH with moderate to advanced liver fibrosis, in conjunction with diet and exercise.
What’s next in line for fatty liver disease? – NASH News
Madrigal Pharmaceuticals celebrates EMA’s validation of the Marketing Authorization Application for Resmetirom, a potential breakthrough therapy for NASH/MASH with liver fibrosis, while eagerly awaiting FDA’s decision, marking significant progress in the fight against liver-related mortality in Europe.
Congress looking to wrap up FY2024 spending bills as they look ahead to FY 2025 appropriations – Liver Health Policy Update
Congress continues to narrowly avert a government shutdown, most recently with yet another Continuing Resolution to extend government funding through later in March.
Navigating Liver Cancer Care – Liver Cancers News
Please join us on April 18 for a liver cancer care webinar open to patients, caregivers, and health care professionals. Experts will discuss topics relevant to the care and treatment of liver cancer and its symptoms so that patients and providers alike can make informed care decisions.
Rare Advocacy on Capitol Hill, in the White House, & Beyond! – Pediatric & Rare Liver Diseases News
In February, GLI raised awareness and amplified the patient voice in discussions about transitions in care for rare liver diseases. Here are a few highlights.
6 Ways to Ease Financial Stress for Patients with Chronic Liver Conditions
Dr. Ufere spoke with GLI about the financial insecurities of patients with chronic liver disease. In her experience, the decision to seek medical care often boils down to affordability, at the end of the day.
Navigating the Niche Nutritional Challenges of Rare Liver Diseases
The lifestyle changes that come with a rare liver disease or any chronic condition can be daunting and frustrating. With a diet change, your meals, grocery bills, and even restaurant menus start to look different, not to mention the lists and diet recommendations from doctors that can be long and overwhelming.
Six Tips to Help Your Patients through Organ Transplantation
Dr. Alin Gragossian is a physician trained in both emergency medicine and critical care medicine at Equum Medical. Beyond her clinical roles, she serves as an associate medical director at Donor Network West, a nonprofit, organ procurement and tissue recovery organization serving Nevada and California. Notably, Dr. Gragossian brings a unique perspective to her work, having undergone a heart transplant in 2019 at the age of 30.
Congress passes Continuing Resolution to extend federal funding into March 2024
Congress has again averted a government shutdown through the passage of a Continuing Resolution (CR) for funding the government into early March 2024. Election year politics make bipartisanship essential to advancing key legislation in the House and Senate. The current administration will be looking to finalize program regulations and advance key administration priorities before the elections.
GLI VP Raises NASH Awareness in the Managed Care Community – NASH News
Jeff McIntyre Raises NASH Awareness Among Health Care Community, Fatty Liver Disease More Fatal for Women, and more!
It’s Rare Liver Diseases Month! – Pediatric & Rare Liver Diseases News
It’s Rare Liver Diseases Month!
If you haven’t already, join us for the 2024 #RareAware multifaceted campaign, focusing on the theme of “Transitions in Care During.”